These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15194347)

  • 1. Rejection of grafts without histocompatibility antigen disparity by TAP1-/- mice: a role for CD4+ T cells.
    Marrero I; Benvenutti LA; Noronha I; Kalil J; Coelho V
    Transplant Proc; 2004 May; 36(4):999-1000. PubMed ID: 15194347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.
    Suárez IM; Benvenutti LA; Noronh I; Van Kaer L; Kalil J; Coelho V
    Transpl Immunol; 2002 May; 9(2-4):101-10. PubMed ID: 12180815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors.
    Marrero I; Benvenutti LA; Kalil J; Coelho V
    Immunology; 2005 Aug; 115(4):484-94. PubMed ID: 16011517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigens.
    Marrero I; Huffman D; Kalil J; Sercarz EE; Coelho V
    Immunology; 2006 Aug; 118(4):461-71. PubMed ID: 16895555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
    Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
    Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
    Rosenberg AS
    Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
    [No Abstract]   [Full Text] [Related]  

  • 10. Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.
    Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG
    J Immunol; 1998 Jan; 160(2):572-9. PubMed ID: 9551890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
    Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
    Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
    Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAP1 mutant mice reject heart grafts from donors with no MHC disparity.
    Coelho V; Marrero I; Noronha I; Benvenuti LA; Van Kaer L; Kalil J
    Transplant Proc; 1999; 31(1-2):900-1. PubMed ID: 10083397
    [No Abstract]   [Full Text] [Related]  

  • 15. CD4+ T cells are able to reject class I disparate allografts.
    Sawada T; Wu Y; Sachs DH; Iacomini J
    Transplantation; 1997 Jul; 64(2):335-40. PubMed ID: 9256197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.
    Shen C; He Y; Cheng K; Zhang D; Miao S; Zhang A; Meng F; Miao F; Zhang J
    Immunol Lett; 2011 Aug; 138(2):144-55. PubMed ID: 21513739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.
    Kobayashi E; Kawai K; Ikarashi Y; Fujiwara M
    J Exp Med; 1992 Aug; 176(2):617-21. PubMed ID: 1354244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.